IASLC: Non-Small LUNG CANCER

NEW DEVELOPMENTS IN NON-SMALL LUNG CANCER - A new web-based CME program

	Inbox		X

Reply

Paul Bunn, Jr, MD of IASLC  to me

show details 22:45 (8 hours ago)

Images are not displayed.
Display images below - Always display images from iaslc@clinicalinsights.net

Having trouble viewing this email? Click here

IASLC introduces new educational offerings on its website to its membership and healthcare professionals who manage patients with lung cancer.  The first program, "New Developments in Non-Small Cell Lung Cancer" features three presentations.  In a two-part presentation, Professor Peter Goldstraw, MD reviews the fundaments of the new lung cancer staging system, and examines the role of TNM in the staging of patients with small cell lung cancer.  The new, updated IASLC nodal staging map is also reviewed.  In another presentation, Dr. Paul Bunn, Jr. addresses the incorporation of molecular testing into the standard diagnostic workup of patients with NSCLC, and the selection of appropriate treatment for patients.  The program concludes with case presentations by Drs. Paul Bunn Jr., and Harvey I. Pass illustrating the use of the new staging system and molecular testing. IASLC  Click to View Presentation   Peter Goldstraw, MD    The New Lung Cancer Staging System: Part 1 The Fundaments of the 7th Edition of the TNM Classification of Malignant Tumors The New Lung Cancer Staging System: Part 2 Supplementary Clarification for the 7th Edition of the TNM Classification of Malignant Tumors Click to View Presentation   Paul A. Bunn, Jr., MD    Genetic Testing for Optimal Therapy of Non-Small-Cell Lung Cancer Click to View Presentation  Case Study Presentations: Staging of Non-Small-Cell Lung Cancer Using the New System Genetic Testing for Optimal Therapy of Non-Small-Cell Lung Cancer Paul A Bunn, Jr., MD Harvey I. Pass, MD Beginning in March 2011, IASLC plans to offer  a series of live webinars throughout the year to provide clinicians with the opportunity to interact with IASLC faculty members on clinical practice issues including the new Lung Cancer Staging System and the use of genetic testing. Become a Member    Register Now    News    Contact Us       14th Annual Conference on  Lung Cancer    Amsterdam,  The Netherlands   July 3-7, 2011    General Information    Conference Info     Contact Us       Physicians: Jointly sponsored by the International Association for the Study of Lung Cancer and the University of Colorado School of Medicine, Office of Continuing Medical Education. Supported in part by an educational grant from OSI Pharmaceuticals, Inc. For more information visit www.iaslc.org Copyright 2010 International Association for the Study of Lung Cancer. All rights reserved. Address: 12801 East 17th Avenue, Mail Stop 8117, Aurora, Colorado 80045